论文部分内容阅读
美国当地时间5月31日11时,生物股份旗下金宇美国生物技术有限公司(以下简称“金宇美国公司”)成立揭牌仪式在堪萨斯州曼哈顿市隆重举行。这是首家由中国动保企业在堪萨斯城动物卫生走廊设立的生物技术公司,也是金宇生物股份有限公司(以下简称“金宇生物股份”)践行国际化战略的重要一步。应邀出席揭牌仪式的嘉宾有60多名来自政府、大学、动保界和商界的
At 11 o’clock on the May 31st, local time of U.S.A., the inauguration ceremony of Jinyu American Biotechnology Co., Ltd. (hereinafter referred to as “Jinyu American Company”), a subsidiary of Biomass Corporation, was held ceremoniously in Manhattan, Kansas. This is the first biotechnology company to be set up by the China Animal Health and Safety Corporation in the Kansas City Animal Health Corridor. It is also an important step in the internationalization strategy of Jinyu Biological Co., Ltd. (hereinafter referred to as “Jinyu Biological Shares”). More than 60 guests invited to attend the inauguration ceremony came from the government, universities, mobile insurance industry and the business community